Linqi Zhang

Dr. Linqi Zhang received his doctoral degree in 1992 from University of Edinburgh, where he stayed and worked as postdoctoral fellow from 1992 to 1993. He then held associate professorship at the Aaron Diamond AIDS Research Center of Rockefeller University in New York for a couple of years before joining Tsinghua University in 2007. Professor Zhang has devoted 30 years to studying HIV-1 pathogenesis and vaccine development, and recently expanded his research into emerging and re-emerging human viral pathogens such as highly pathogenic avian influenza virus (HPAI), Middle East respiratory syndrome coronavirus (MERS-CoV), Ebola and Zika virus. Using cutting-edge antibody and combinatorial antigen library techniques, Professor Zhang’s team aims to characterize protective antibody immunity in infected humans and rationally design of effective vaccines and therapeutics against the viral infection. Professor Zhang is currently the Director of Comprehensive AIDS Research Center and Global Health and Infectious Diseases Research Center at Tsinghua University. He is the recipient of National Outstanding Young Scientist Award and privileged Changjiang Professorship. Besides, he has published extensive research papers and ranked No. 1 among the most cited Chinese Researchers in the field of microbiology and immunology surveyed by Elsevier in 2014, 2015 and 2016. Professor Zhang has also been serving as the member of national expert and advisory board to the Chinese government and several international organizations on HIV/AIDS and infectious diseases and recently been elected to the foreign fellow of African Academy of Sciences.

Lab Information

School of Medicine Tsinghua University

Research Area and Skills

Recognize this scientist’s Expertise for their contribution in your research

HIV 0 pathogenesis 0 antibody 0 vaccine 0 emerging infectious diseases 0 global health and infectious diseases 0

More

  • Post
  • Publication
  • Plasmid
  • Following (0)
  • Follower (1)


This guy hasn’t posted anything yet.

Hot Posts for You

Neutralizing antibodies (NAbs) are critical human immune defense mechanisms against viral infections. NAbs can bind to sites on the virus and inhibit entry of that virus into the host. It is a key parameter to evaluate COVID-19 vaccine efficacy per Guidelines from Development and ...Learn More


This 3D animation shows you how DNA is copied in a cell. It shows how both strands of the DNA helix are unzipped and copied to produce two identical DNA molecules. TranscriptDNA is a molecule made up of two strands twisted around each other in a double helix shape. Each strand is ...Learn More


IntroductionA gleam of light finally shone down on the global crisis of the prolonged battle against COVID-19, giving people hopes of preventive care and treatment in the near future by monoclonal antibodies against SARS-CoV-2. As stated the news of NIH’s phase III clinical ...Learn More


"Those who do not know history are obliged to repeat it" This famous phrase that could be from any history teacher to his suspended students has been attributed to great figures in history such as Napoleon or the philosopher George Santayana. In a modern version of it we could say ...Learn More


In recent years there is an increasing number of cytotoxic chemotherapeutic compounds with the ability to rapidly kill dividing cancer cells in preference to non-dividing healthy cells. Nevertheless, the major drawback of chemotherapy is that, in addition to damaging the cancer ...Learn More


The coronavirus pandemic caught everyone unprepared. We had to deal with the fear of an unknown virus which can be lethal for some people. And the whole world just stopped in an attempt to prevent the virus spread.Suddenly we had to adapt to a new way of living, socially isolated ...Learn More


This is the first episode of MolecularCloud Pioneer Scientist interview series. In this interview, MolecularCloud talks with Prof. Shuo Huang from Nanjing University about the recent publications of Dr. Huang’s team and the future prospect of biological nanopore technology. The ...Learn More


The increasing number of confirmed COVID-19 cases is prompting an unprecedented global effort to find a treatment for the disease. Given the fact that a new drug development could be a decade work from initial discovery to the marketplace, scientists are racing to search a cure ...Learn More


The previous article on precision medicine was focused on Pharmacogenomics as a fundamental aspect of cancer therapeutics. In this sequel, emphasis would be on the role of immuno-oncology in personalization of cancer therapy, citing anti PD therapy as an example with hypothetical ...Learn More


  1. Lan, J., Ge, J., Yu, J., Shan, S., Zhou, H., Fan, S., ... & Wang, X. (2020). Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature, 581(7807), 215-220.

  2. Zhou P, Wang H, Fang M, Li Y, Wang H, Shi S, Li Z, Wu J, Han X, Shi X, Shang H, Zhou T, Zhang L. 2019. Broadly resistant HIV-1 against CD4-binding site neutralizing antibodies. PLoS Pathog 15:e1007819.

  3. Xu J, Jia W, Wang P, Zhang S, Shi X, Wang X, Zhang L. 2019. Antibodies and vaccines against Middle East respiratory syndrome coronavirus. Emerg Microbes Infect 8:841-856.

  4. Wang Q, Liu L, Ren W, Gettie A, Wang H, Liang Q, Shi X, Montefiori DC, Zhou T, Zhang L. 2019. A Single Substitution in gp41 Modulates the Neutralization Profile of SHIV during In Vivo Adaptation. Cell Rep 27:2593-2607.e5.

  5. Wang P, Zuo Y, Sun J, Zuo T, Zhang S, Guo S, Shi X, Liang M, Zhou P, Zhang L, Wang X. 2019. Structural and functional definition of a vulnerable site on the hemagglutinin of highly pathogenic avian influenza A virus H5N1. J Biol Chem 294:4290-4303.

  6. Wang L, Wang R, Wang L, Ben H, Yu L, Gao F, Shi X, Yin C, Zhang F, Xiang Y, Zhang L. 2019. Structural Basis for Neutralization and Protection by a Zika Virus-Specific Human Antibody. Cell Rep 26:3360-3368.e5.

  7. Li G, Jiang Y, Zhang L. 2019. HIV upsurge in China's students. Science 364:711.

  8. Jia W, Channappanavar R, Zhang C, Li M, Zhou H, Zhang S, Zhou P, Xu J, Shan S, Shi X, Wang X, Zhao J, Zhou D, Perlman S, Zhang L. 2019. Single intranasal immunization with chimpanzee adenovirus-based vaccine induces sustained and protective immunity against MERS-CoV infection. Emerg Microbes Infect 8:760-772.


This guy hasn’t plasmids anything yet.

Hot plasmids


This guy has no following anyone.

Popular Cloud Scientists

Cloud Scientists

About Us · User Accounts and Benefits · Privacy Policy · Management Center · FAQs
© 2025 MolecularCloud